Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Most read article(s)

  • You have accessRestricted access
    Proliferation Response of Leukemic Cells to CD70 Ligation Oscillates with Recurrent Remission and Relapse in a Low-Grade Lymphoma
    Yael Kaufmann, Ninette Amariglio, Esther Rosenthal, Yasmine Jacob Hirsch, Amira Many and Gideon Rechavi
    J Immunol 175 (10) 6940-6947; November 15, 2005, doi: https://doi.org/10.4049/jimmunol.175.10.6940
  • You have accessRestricted access
    Secondary Lymphoid Organs: Responding to Genetic and Environmental Cues in Ontogeny and the Immune Response
    Nancy H. Ruddle and Eitan M. Akirav
    J Immunol 183 (4) 2205-2212; August 15, 2009, doi: https://doi.org/10.4049/jimmunol.0804324
  • You have accessRestricted access
    Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns
    Nicole Baumgarth, Janko Nikolich-Žugich, F. Eun-Hyung Lee and Deepta Bhattacharya
    J Immunol 205 (9) 2342-2350; November 1, 2020, doi: https://doi.org/10.4049/jimmunol.2000839
  • You have accessRestricted access
    COVID-19 as an Acute Inflammatory Disease
    Rose H. Manjili, Melika Zarei, Mehran Habibi and Masoud H. Manjili
    J Immunol 205 (1) 12-19; July 1, 2020, doi: https://doi.org/10.4049/jimmunol.2000413
  • You have accessRestricted access
    A Beginner’s Guide to Analyzing and Visualizing Mass Cytometry Data
    Abigail K. Kimball, Lauren M. Oko, Bonnie L. Bullock, Raphael A. Nemenoff, Linda F. van Dyk and Eric T. Clambey
    J Immunol 200 (1) 3-22; January 1, 2018, doi: https://doi.org/10.4049/jimmunol.1701494
  • Open Access
    Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
    Philipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, Ngan Nguyen, Federica Morandi, Jared Head, Alison O’Mahony, Simone C. Zimmerli, Lisa Bruns, Andrew T. Bender, Patricia Schroeder and Roland Grenningloh
    J Immunol 202 (10) 2888-2906; May 15, 2019, doi: https://doi.org/10.4049/jimmunol.1800583
  • You have accessRestricted access
    Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
    Eleni Vergadi, Eleftheria Ieronymaki, Konstantina Lyroni, Katerina Vaporidi and Christos Tsatsanis
    J Immunol 198 (3) 1006-1014; February 1, 2017, doi: https://doi.org/10.4049/jimmunol.1601515
  • You have accessRestricted access
    Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19
    Jeremy K. Y. Yap, Miyu Moriyama and Akiko Iwasaki
    J Immunol 205 (2) 307-312; July 15, 2020, doi: https://doi.org/10.4049/jimmunol.2000513
  • You have accessRestricted access
    M1 Means Kill; M2 Means Heal
    Klaus Ley
    J Immunol 199 (7) 2191-2193; October 1, 2017, doi: https://doi.org/10.4049/jimmunol.1701135
  • You have accessRestricted access
    Long Term Maintenance of IgE-Mediated Memory in Mast Cells in the Absence of Detectable Serum IgE
    Shuichi Kubo, Toshinori Nakayama, Kunie Matsuoka, Hiromichi Yonekawa and Hajime Karasuyama
    J Immunol 170 (2) 775-780; January 15, 2003, doi: https://doi.org/10.4049/jimmunol.170.2.775

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606